sk chemicals co
Sanofi Pasteur, SK Chemicals To Co-Develop Pneumococcal Vaccine
Vaccine-maker Sanofi Pasteur will invest US$23 million in South Korea’s SK Chemicals for the development of pneumococcal conjugate vaccine.
Vaccine-maker Sanofi Pasteur will invest US$23 million in South Korea’s SK Chemicals for the development of pneumococcal conjugate vaccine.
